Canaccord Genuity Initiates Coverage On Progyny with Buy Rating, Announces Price Target of $46
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Richard Close has initiated coverage on Progyny (NASDAQ:PGNY) with a Buy rating and a price target of $46.
September 27, 2023 | 9:00 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Progyny's stock may see a positive impact due to the Buy rating and price target of $46 announced by Canaccord Genuity.
Analyst ratings often influence the market's perception of a stock. In this case, Canaccord Genuity's Buy rating and price target of $46 for Progyny could lead to increased investor interest and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100